98%
921
2 minutes
20
Major depressive disorder (MDD) is characterized by intercorrelated clinical symptoms and cognitive deficits, whose neural mechanisms in relation to these disturbances remain unclear. To elucidate this, we applied the relatively new approach of Network Control Theory (NCT), which considers how network topology informs brain dynamics based on white matter connectivity data. We used the NCT parameter of average controllability (AC) to assess the potential control that brain network nodes have on brain-state transitions associated with clinical and cognitive symptoms in MDD. DTI and high-resolution T1-weighted anatomical imaging were performed on 170 MDD patients (mean age 31.6 years; 72 males, 98 females) and 137 healthy controls (HC; mean age 33.4 years; 64 males, 73 females). We used an NCT approach to compare AC between the groups. We then performed partial Spearman's rank correlation and moderation/mediation analyses for AC and cognition and clinical symptom scores. Compared with HC, MDD patients had lower AC in the left precuneus and superior parietal lobule and higher AC in the right precentral gyrus (preCG) and superior frontal gyrus (SFG), predominantly in the default-mode, somatomotor, and attention networks. In the HC group, AC of right preCG was positively associated with processing speed. While in the MDD group, AC of right SFG was negatively associated with memory function and also negatively moderated the association between memory and anxiety symptoms. The current study highlighted that the altered brain controllability may provide a novel understanding of the neural substrate underlying cognitive control in MDD. Disrupted control of right SFG during state transitions may partially explain the variable relationship between memory and anxiety symptoms in MDD.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11923719 | PMC |
http://dx.doi.org/10.1002/hbm.70198 | DOI Listing |
Neuro Endocrinol Lett
September 2025
Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Background: Major depressive disorder (MDD) is associated with neuro-immune - metabolic - oxidative (NIMETOX) pathways.
Aims: To examine the connections among NIMETOX pathways in outpatient MDD (OMDD) with and without metabolic syndrome (MetS); and to determine the prevalence of NIMETOX aberrations in a cohort of OMDD patients.
Methods: We included 67 healthy controls and 66 OMDD patients and we assessed various NIMETOX pathways.
Trends Psychiatry Psychother
September 2025
Laboratory of Hormone Measurement, Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, Brazil. Postgraduate Program in Psychobiology, Center for Biosciences, Federal University of Rio Grande do Norte, Natal, Brazil. National Institute of Science and Technology fo
Background: Major Depressive Disorder (MDD) is a leading cause of global disability, contributing to substantial individual, social, and economic burdens. While antidepressant therapy remains the cornerstone of treatment, complementary lifestyle-based interventions, such as multimodal exercise and mindfulness, have shown promise in alleviating mood symptoms. However, their specific impact on sleep quality, a critical therapeutic target in MDD, remains underexplored.
View Article and Find Full Text PDFJAMA Psychiatry
September 2025
Denovo Biopharma LLC, San Diego, California.
Importance: This study represents a first successful use of a genetic biomarker to select potential responders in a prospective study in psychiatry. Liafensine, a triple reuptake inhibitor, may become a new precision medicine for treatment-resistant depression (TRD), a major unmet medical need.
Objective: To determine whether ANK3-positive patients with TRD benefit from a 1-mg and/or 2-mg daily oral dose of liafensine, compared with placebo, in a clinical trial.
Metab Brain Dis
September 2025
Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277, Jiefang Avenue, Wuhan, Hubei, 430022, China.
Major depression disorder (MDD) is a mental condition that significantly threatens both physical and psychological health. This study aimed to discern variances in plasma metabolic profiles between MDD sufferers and healthy counterparts. Additionally, we tracked the hospitalization journey of MDD patients to investigate the normalization of metabolic irregularities through conventional treatment in the form of self-control.
View Article and Find Full Text PDFInt J Soc Psychiatry
September 2025
Department of Community Medicine, All India Institute of Medical Sciences, Nagpur, MH, India.
Introduction: Night Eating Syndrome (NES) is a distinct psychopathological entity variously considered as a mental health disorder, eating disorder or circadian rhythm disorder. Medical students are faced with hectic schedules, sleep interruptions and high-stakes exams as they become healthcare providers. Such social factors coupled with poor dietary practices may impact their mental health and biological clocks, leading to NES amongst this population.
View Article and Find Full Text PDF